BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23640805)

  • 1. O-GlcNAcomics--Revealing roles of O-GlcNAcylation in disease mechanisms and development of potential diagnostics.
    Copeland RJ; Han G; Hart GW
    Proteomics Clin Appl; 2013 Oct; 7(9-10):597-606. PubMed ID: 23640805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for Enrichment and Assignment of N-Acetylglucosamine Modification Sites.
    Maynard JC; Chalkley RJ
    Mol Cell Proteomics; 2021; 20():100031. PubMed ID: 32938750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Chemoenzymatic Histology Method for O-GlcNAc Detection.
    Aguilar AL; Hou X; Wen L; Wang PG; Wu P
    Chembiochem; 2017 Dec; 18(24):2416-2421. PubMed ID: 29044951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional crosstalk among oxidative stress and O-GlcNAc signaling pathways.
    Chen PH; Chi JT; Boyce M
    Glycobiology; 2018 Aug; 28(8):556-564. PubMed ID: 29548027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 2D and 3D cell culture protocol to study O-GlcNAc in sphingosine-1-phosphate mediated fibroblast contraction.
    Morales MM; Pedowitz NJ; Pratt MR
    STAR Protoc; 2022 Mar; 3(1):101113. PubMed ID: 35118425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK).
    Bullen JW; Balsbaugh JL; Chanda D; Shabanowitz J; Hunt DF; Neumann D; Hart GW
    J Biol Chem; 2014 Apr; 289(15):10592-10606. PubMed ID: 24563466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAc profiling: from proteins to proteomes.
    Ma J; Hart GW
    Clin Proteomics; 2014 Mar; 11(1):8. PubMed ID: 24593906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative phosphoproteomics reveals crosstalk between phosphorylation and O-GlcNAc in the DNA damage response pathway.
    Zhong J; Martinez M; Sengupta S; Lee A; Wu X; Chaerkady R; Chatterjee A; O'Meally RN; Cole RN; Pandey A; Zachara NE
    Proteomics; 2015 Jan; 15(2-3):591-607. PubMed ID: 25263469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Spectrometry-Based Quantitative O-GlcNAcomic Analysis.
    Ma J; Hart GW
    Methods Mol Biol; 2016; 1410():91-103. PubMed ID: 26867740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAc transferase inhibitors: current tools and future challenges.
    Trapannone R; Rafie K; van Aalten DM
    Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cracking the O-GlcNAc code in metabolism.
    Ruan HB; Singh JP; Li MD; Wu J; Yang X
    Trends Endocrinol Metab; 2013 Jun; 24(6):301-9. PubMed ID: 23647930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic approaches for site-specific O-GlcNAcylation analysis.
    Wang S; Yang F; Camp DG; Rodland K; Qian WJ; Liu T; Smith RD
    Bioanalysis; 2014; 6(19):2571-80. PubMed ID: 25411699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three Decades of Research on O-GlcNAcylation - A Major Nutrient Sensor That Regulates Signaling, Transcription and Cellular Metabolism.
    Hart GW
    Front Endocrinol (Lausanne); 2014; 5():183. PubMed ID: 25386167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple tissue-specific roles for the O-GlcNAc post-translational modification in the induction of and complications arising from type II diabetes.
    Vaidyanathan K; Wells L
    J Biol Chem; 2014 Dec; 289(50):34466-71. PubMed ID: 25336652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer metabolism and elevated O-GlcNAc in oncogenic signaling.
    Ma Z; Vosseller K
    J Biol Chem; 2014 Dec; 289(50):34457-65. PubMed ID: 25336642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular O-linked β-N-acetylglucosamine: Its biology and relationship to human disease.
    Ogawa M; Furukawa K; Okajima T
    World J Biol Chem; 2014 May; 5(2):224-30. PubMed ID: 24921011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptide panel investigation reveals the acceptor specificity of O-GlcNAc transferase.
    Liu X; Li L; Wang Y; Yan H; Ma X; Wang PG; Zhang L
    FASEB J; 2014 Aug; 28(8):3362-72. PubMed ID: 24760753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein O-GlcNAcylation in diabetes and diabetic complications.
    Ma J; Hart GW
    Expert Rev Proteomics; 2013 Aug; 10(4):365-80. PubMed ID: 23992419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats.
    Kreppel LK; Blomberg MA; Hart GW
    J Biol Chem; 1997 Apr; 272(14):9308-15. PubMed ID: 9083067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular imprinting of magnetic nanoparticles with boric acid affinity for the selective recognition and isolation of glycoproteins.
    Wang B; Duan A; Xie S; Zhang J; Yuan L; Cao Q
    RSC Adv; 2021 Jul; 11(41):25524-25529. PubMed ID: 35478904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.